Bell’s Palsy News and Research

RSS

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Study investigates the link between COVID-19 vaccines and autoimmune/neurological diseases, focusing on Guillain-Barre syndrome (GBS) risks associated with adenovirus vector vaccines.

16 Jan 2024

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

Study describes health outcomes following simultaneous vaccination with monovalent primary series COVID-19 vaccines

Researchers described simultaneous vaccination with primary series SARS-CoV-2 vaccines

19 Jun 2023

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Study evaluates the risk of post-acute sequelae of COVID-19 in the United Kingdom (UK) and Hong Kong (HK).

30 May 2023

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

Researchers evaluated adverse events in older adults after mRNA vaccination for COVID-19.

24 Jan 2023

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

A recent Eurosurveillance study focused on estimating the incidence of a prespecified list of adverse events following the first and second doses of the COVID-19 vaccination.

23 Jan 2023

Researchers explore neurological manifestations among long COVID patients

In a new study, researchers assessed the long-term neurological sequelae in the post-acute phase of coronavirus disease 2019 (COVID-19) or long COVD.

26 Sep 2022

Children with Bell's palsy recover without medication within six months

Most children with a condition that causes a temporary weakness or paralysis of the muscles in the face recover without medication within six months, according to a new study.

9 Sep 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

In a new study, a team of researchers estimated the pre-pandemic incidence rates of adverse events of special interest now observed in association with COVID-19 vaccines in Canada.

18 Jan 2022

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

A deep look into a nationwide mass vaccination setting in Israel revealed that the BNT162b2 (Pfizer–BioNTech) vaccine is not linked with an elevated risk of a majority of the adverse events under study, with the exception of myocarditis. However, even that potentially severe adverse event is much more pervasive following the infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), found a new study published in the New England Journal of Medicine (NEJM).

30 Aug 2021

Beneficial and protective effects of SARS-CoV-2 vaccines far outweigh the risk of Bell's palsy

The first large-scale population-based study on the association between the SARS-CoV-2 vaccines and Bell's palsy confirms that the beneficial and protective effects of the vaccines far outweigh the risk of this rare adverse event.

16 Aug 2021

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

The case of a patient who experienced two facial palsies – one after the first and another after the second dose of the Pfizer-BioNTech COVID-19 vaccine – strongly suggests that Bell’s palsy (facial nerve palsy of unknown cause) is linked to the Pfizer-BioNTech vaccine, doctors write in the journal BMJ Case Reports.

19 Jul 2021

Migraine headache may double risk of nervous system condition that causes Bell's palsy

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

17 Dec 2014

Bell’s Palsy News and Research

Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

Study describes health outcomes following simultaneous vaccination with monovalent primary series COVID-19 vaccines

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Analysis of adverse events in older US adults after COVID-19 mRNA vaccination

What was the prevalence of adverse events following first and second dose COVID-19 vaccinations in England?

Researchers explore neurological manifestations among long COVID patients

Children with Bell's palsy recover without medication within six months

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Study predicts incidence rates of adverse outcomes of COVID-19 vaccination

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Large Israeli study offers detailed look at safety profile of mRNA vaccine against SARS-CoV-2

Beneficial and protective effects of SARS-CoV-2 vaccines far outweigh the risk of Bell's palsy

Patient's case report reveals link between Bell’s palsy and Pfizer-BioNTech vaccine

Migraine headache may double risk of nervous system condition that causes Bell's palsy

Botox also treats facial nerve disorders that occur after Bell's palsy

Emergency physicians correctly identify nearly 100% of patients with Bell's palsy

Loyola University surgeon uses electrical stimulation as part of surgical technique to treat Bell's palsy

Intense acupuncture shows promise for Bell’s palsy rehabilitation

Herpes zoster vaccine safe and well tolerated: Study

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News